Benefit of Oleuropein Aglycone for Alzheimer's Disease by Promoting Autophagy.

dc.contributor.authorCordero, Joaquín G
dc.contributor.authorGarcía-Escudero, Ramón
dc.contributor.authorAvila, Jesús
dc.contributor.authorGargini, Ricardo
dc.contributor.authorGarcía-Escudero, Vega
dc.date.accessioned2025-01-07T13:20:11Z
dc.date.available2025-01-07T13:20:11Z
dc.date.issued2018-02-20
dc.description.abstractAlzheimer's disease is a proteinopathy characterized by accumulation of hyperphosphorylated Tau and β-amyloid. Autophagy is a physiological process by which aggregated proteins and damaged organelles are eliminated through lysosomal digestion. Autophagy deficiency has been demonstrated in Alzheimer's patients impairing effective elimination of aggregates and damaged mitochondria, leading to their accumulation, increasing their toxicity and oxidative stress. In the present study, we demonstrated by microarray analysis the downregulation of fundamental autophagy and mitophagy pathways in Alzheimer's patients. The benefits of the Mediterranean diet on Alzheimer's disease and cognitive impairment are well known, attributing this effect to several polyphenols, such as oleuropein aglycone (OLE), present in extra virgin olive oil. OLE is able to induce autophagy, achieving a decrease of aggregated proteins and a reduction of cognitive impairment in vivo. This effect is caused by the modulation of several pathways including the AMPK/mTOR axis and the activation of autophagy gene expression mediated by sirtuins and histone acetylation or EB transcription factor. We propose that supplementation of diet with extra virgin olive oil might have potential benefits for Alzheimer's patients by the induction of autophagy by OLE.
dc.identifier.doi10.1155/2018/5010741
dc.identifier.essn1942-0994
dc.identifier.pmcPMC5838478
dc.identifier.pmid29675133
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC5838478/pdf
dc.identifier.unpaywallURLhttp://downloads.hindawi.com/journals/omcl/2018/5010741.pdf
dc.identifier.urihttps://hdl.handle.net/10668/25442
dc.journal.titleOxidative medicine and cellular longevity
dc.journal.titleabbreviationOxid Med Cell Longev
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.page.number5010741
dc.pubmedtypeJournal Article
dc.pubmedtypeReview
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshAcetates
dc.subject.meshAlzheimer Disease
dc.subject.meshAnimals
dc.subject.meshAutophagy
dc.subject.meshCyclopentane Monoterpenes
dc.subject.meshHumans
dc.subject.meshPyrans
dc.subject.meshTOR Serine-Threonine Kinases
dc.titleBenefit of Oleuropein Aglycone for Alzheimer's Disease by Promoting Autophagy.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number2018

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC5838478.pdf
Size:
2.55 MB
Format:
Adobe Portable Document Format